Pharmafile Logo
Pharmafocus logo
Advanced Search

Benicar

Showing 3 posts of 3 posts found.

daiichi_sankyo_1_0

Daiichi settles undisclosed drug side-effects case for $300 million

August 2, 2017
Research and Development, Sales and Marketing Benicar, Daiichi Sankyo, biotech, drugs, pharma, pharmaceutical

Daiichi Sankyo has settled a case alleging that it did not fully disclose adverse side-effects of its drug, Benicar, with …

News
Daiichi image

Daiichi Sankyo cuts 16% of US staff

March 27, 2015
Sales and Marketing Benicar, Daiichi Sankyo, FDA, Ranbaxy, Welchol, ambit, colesevelam, cuts, olmesartan

Daiichi Sankyo is laying off 16% of its staff at its US commercial headquarters as the company braces itself for …

News
Daiichi image

Daiichi-Sankyo pays $39m to settle allegations

January 12, 2015
Sales and Marketing Azor, Benicar, Daiichi Sankyo, Daiichi-Sankyo, Tribenzor, Welchol, kickbacks, us justice

Daiichi-Sankyo will pay the US government and state Medicaid programmes $39 million to resolve claims that it violated the False …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026